| FusionPlex Panel | Targeted Genes |
|---|---|
| Archer_FusionPlex_FGFR_Panel | FGFR2 |
| Archer_FusionPlex_Heme_V2_Panel | ALK |
| Archer_FusionPlex_Lymphoma_Panel | ALK |
| Archer_FusionPlex_Myeloid_Panel | FGFR2 |
| Archer_FusionPlex_NTRK_Panel | NTRK2 |
| Archer_FusionPlex_Pan-Heme_Panel | ALK, FGFR2 |
| Archer_FusionPlex_Sarcoma_Panel | ALK |
| Archer_FusionPlex_SolidTumor_Panel | ALK, FGFR2, NTRK2 |
| Custom Assay Designer | |
| VCL |
|---|
| PubMed Results |
| UCSC Gene Details |
| OMIM Details |
| NCBI Gene Details |
| Fusion Partners | Original Annotation | Diseases | PubMed Evidence | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VCL:ALK
|
|
5 | ||||||||||
|
VCL:NTRK2
|
|
2 | ||||||||||
|
VCL:FGFR2
|
|
1 | ||||||||||
|
VCL:SEC24C
|
|
1 | ||||||||||
|
||||||||||||
|
VCL:TLE3
|
|
1 | ||||||||||